Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 064117

Expand all

MITOMYCIN (MITOMYCIN)
20MG/VIAL
Marketing Status: Prescription

Active Ingredient: MITOMYCIN
Proprietary Name: MITOMYCIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A064117
Product Number: 002
Approval Date: Apr 19, 1995
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

MITOMYCIN (MITOMYCIN)
40MG/VIAL
Marketing Status: Prescription

Active Ingredient: MITOMYCIN
Proprietary Name: MITOMYCIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A064117
Product Number: 003
Approval Date: Jun 2, 1999
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

MITOMYCIN (MITOMYCIN)
5MG/VIAL
Marketing Status: Discontinued

Active Ingredient: MITOMYCIN
Proprietary Name: MITOMYCIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A064117
Product Number: 001
Approval Date: Apr 19, 1995
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information